secwatch.observer — SEC 8-K summary
======================================

Issuer:     Damora Therapeutics, Inc. (DMRA)
CIK:        0001800315
Form:       8-K
Filed at:   2024-09-18T23:59:59+00:00
Accession:  0000950170-24-107580
Event type: regulatory
Sentiment:  positive
Materiality: 0.55
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Galecto regains Nasdaq minimum bid price compliance; matter closed
------------------------------------------------------------------

- Received Nasdaq Staff letter confirming compliance with Rule 5550(a)(2) based on bid price >= $1.00 from Aug 30 to Sep 13, 2024.
- The deficiency notice is now closed; no further action required on this matter.
- Shares continue trading on Nasdaq Capital Market under ticker GLTO.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1800315/000095017024107580/0000950170-24-107580-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1800315/000095017024107580/glto-20240916.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-107580

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer